Status:
COMPLETED
An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)
Lead Sponsor:
Organon and Co
Conditions:
Urticaria
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
This is a study to evaluate the efficacy and safety of desloratadine (MK-4117) in Japanese participants with chronic urticaria. The primary hypothesis is that the efficacy of desloratadine 10 mg and 5...
Eligibility Criteria
Inclusion
- Chronic urticaria \[rash (erythema, wheal) for more than 1 month without any known cause\]
- Out-patient
Exclusion
- Stimulation-induced urticaria \[physical urticaria (e.g. cold, solar, and heat urticaria), cholinergic urticaria, contact urticaria)\]
- Hypersensitivity to antihistamines or ingredients of a study drug
Key Trial Info
Start Date :
August 27 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 13 2014
Estimated Enrollment :
239 Patients enrolled
Trial Details
Trial ID
NCT01916967
Start Date
August 27 2013
End Date
March 13 2014
Last Update
June 18 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.